The government is looking to the NHS to produce huge new savings as part of its rescue package for the …
European regulators have recommended Roche's RoActemra be approved to treat moderate to severe rheumatoid arthritis. The novel drug, known as …
Doctors and nurses are to decide on a series of quality indicators that will measure how well the NHS is …
Personal health records will play an important role in the exchange of health informationEarly successes in healthcare interoperability are paving …
The future of UK medicines could be revolutionised by a new deal that contains two pioneering measures on flexible prices …
AstraZeneca has announced the loss of 1,400 jobs in its European manufacturing and supply chain infrastructure.The company says the introduction …
Plans to make Viagra available through pharmacies in Europe without a prescription have been scuppered by safety concerns.Pfizer has ended …
Boehringer Ingelheim's new lung cancer drug Vargatef has entered phase III trials.The drug is part of the manufacturer's burgeoning oncology …
Initiatives to make the UK a world class location for medical research needs significant pharma input to be a success, …
A key NHS reform isn't working and requires a major overhaul, according to a new report by think tank The …
The UK government has agreed a new flexible pricing deal with the industry, in which companies can raise the price …
Pfizer has launched a global stem cell research unit to develop a new generation of medicines.The research unit, to be …
You probably know the type: successful people who apparently ease through their careers, seemingly running on invisible, smooth rails towards …
Targeted cancer drugs like Herceptin and Glivec have greatly improved pharma's oncology pipeline success rates, according to a new study. …
Pharmaceutical companies are increasingly looking to 'managed entry' programmes to build strong relationships with NHS customers and ensure new products …
Key decision makers will shape the biosimilars landscapeWith many biologic drugs used to treat increasingly common diseases such as cancer …
NICE is set to recommend Roche's lung cancer treatment Tarceva after the company agreed to lower the drug's price. The …
More exercise and healthier eating are at the core of the government's new anti-obesity initiative, called Change4Life. Billed this week …
GlaxoSmithKline has announced plans to close its manufacturing site in Dartford in the UK, with operations being phased out over …